Advertisement

AntiVEGF therapy

AntiVEGF therapy

Anti-VEGF, 'vascular endothelial growth factor', medication is a treatment that can help stop the progression of wet AMD. This medication Lucentis (Ranibizumab) has to be injected into the eye using a very fine needle under local anaesthetic. This typically results in prevention of further loss of vision, and can also lead to improved vision. The patient will need to be monitored for further leakage of fluid in the eye.

Eylea (Aflibercept) is also an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage . This typically results in prevention of further loss of vision, and can also lead to improved vision.

Guide to going private

Guide to going private

20 page PDF guide to "going private" for insured and self-paying patients.

  • Advice on choosing a doctor and hospital
  • Checklist for comparing providers
  • Understanding prices

Download >

Costs and funding

Costs and funding

Lowest Average Highest
£558 £1,483 £6,900

Features

Latest news

Two out of five private hospitals in England do not meet safety standards intended to protect the...

KIMS Hospital wins Employer of the Year at the Kent Excellence in Business Awards

KIMS Hospital is rated as 'Good' across all areas of its service just four years after opening

Find a ...

Advertisement
Advertisement
Connect with us on: